Postprandial Blood Glucose Predicts Cardiovascular Events and All-Cause Mortality in Type 2 Diabetes in a 14-Year Follow-Up
Open accessThe DOI matches its Crossref record, with a small difference in title or year; 25 of the 25 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To evaluate whether postprandial blood glucose predicts cardiovascular events and all-cause mortality in type 2 diabetes in a long-term follow-up taking into account A1C and the main cardiovascular risk factors. RESEARCH DESIGN AND METHODS: Consecutive type 2 diabetic patients (n = 505) followed up at our diabetes clinic were evaluated at baseline (1995) for the main cardiovascular risk factors and for five glycemic control parameters (fasting blood glucose, blood glucose 2 h after breakfast, blood glucose 2 h after lunch, blood glucose before dinner, and A1C); all-cause mortality and the first cardiovascular events occurring during the 14-year follow-up were measured. RESULTS: We observed 172 cardiovascular events (34.1% of the population) and 147 deaths (29.1% of the population). Using the Cox analysis with the backward method, we categorized the variables according to the therapeutic targets of the American Diabetes Association. Our observations were as follows. When the five glycemic control parameters were considered together, the predictors were 1) for cardiovascular events, blood glucose 2 h after lunch (hazard ratio 1.507, P = 0.010) and A1C (1.792, P = 0.002); and 2) for mortality, blood glucose 2 h after lunch (1.885, P < 0.0001) and A1C (1.907, P = 0.002). When blood glucose 2 h after lunch and A1C were considered together with the main cardiovascular risk factors, the following glycemic control parameters were predictors: 1) for cardiovascular events, blood glucose 2 h after lunch (1.452, P = 0.021) and A1C (1.732, P = 0.004); and 2) for mortality, blood glucose 2 h after lunch (1.846, P = 0.001) and A1C (1.896, P = 0.004). CONCLUSIONS: In type 2 diabetes, both postprandial blood glucose and A1C predict cardiovascular events and all-cause mortality in a long-term follow-up.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Notably, elevated 2 h postprandial glucose levels have been associated with a 50% greater risk of cardiovascular events and an 89% increase in all‐cause mortality (Cavalot et al., 2011).”
From Acute systemic and energy metabolism responses to velocity-based resistance training following an oral glucose load in individuals with excess body weight (2026) · cites this paper as Cavalot et al., 2011
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Standards of medical care in diabetes 2010
American Diabetes Association (2010) · Diabetes Care · doi:10.2337/dc10-s011 · Cited by 3,470
Monnier, L., Lapinski, H., & Colette, C. (2003) · Diabetes Care · doi:10.2337/diacare.26.3.881 · Cited by 1,461 · cited 1×
“The specific contribution of FBG and postprandial blood glucose to A1C was considered in detail elsewhere (22,23); in our study, the correlation of these two variables with A1C is similar.”
Ray, K. K., Seshasai, S. R. K., Wijesuriya, S., Sivakumaran, R., Nethercott, S., Preiss, D., Erqou, S., & Sattar, N. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60697-8 · Cited by 1,383 · cited 1×
“It has been shown that reduction of hyperglycemia prevents diabetes macrovascular disease; in particular, a metaanalysis of randomized controlled trials evaluating the effects on cardiovascular outcomes and mortality of intensive blood glucose control policies targeting A1C showed a beneficial effect on coronary event…”
BackgroundGlucose Tolerance and Cardiovascular Mortality: Comparison of Fasting and 2-Hour Diagnostic Criteria
(2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.3.397 · Cited by 1,371
Survival as a function of HbA1c in people with type 2 diabetes: a retrospective cohort study
Currie, C. J., Peters, J. R., Tynan, A., Evans, M., Heine, R. J., Bracco, O. L., Zagar, T., & Poole, C. D. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61969-3 · Cited by 874 · cited 3×
“Note also that all patients considered in that study were on hypoglycemic treatment (24): either combination oral regimen with a sulphonylurea plus metformin or insulin, with or without concomitant oral agents; thus, they were at hypoglycemic risk.”
InfluentialHanefeld, M., Fischer, S., Julius, U., Schulze, J., Schwanebeck, U., Schmechel, H., Ziegelasch, H. J., & Lindner, J. (1996) · Diabetologia · doi:10.1007/s001250050617 · Cited by 873 · cited 13×
“Our study, therefore, confirms that which has been observed in the 11-year follow-up of the DIS concerning FBG (9).”
BackgroundResultInfluentialLevitan, E. B., Song, Y., Ford, E. S., & Liu, S. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.19.2147 · Cited by 668 · cited 1×
“Furthermore, a meta-analysis of 38 prospective studies carried out in nondiabetic subjects confirmed a strong association between 2-h postchallenge blood glucose with fatal and nonfatal cardiovascular events (3), and a linear relationship between this parameter and the risk of cardiovascular death has been observed (4…”
BackgroundHanefeld, M. (2004) · European Heart Journal · doi:10.1016/s0195-668x(03)00468-8 · Cited by 641 · cited 1×
“The following evidence is available: 1) a meta-analysis of seven randomized controlled trials in type 2 diabetes indicates that acarbose, a drug that corrects postprandial hyperglycemia by impairing carbohydrate absorption, reduces the occurrence of cardiovascular events; this effect has also been described in patient…”
BackgroundCavalot, F., Petrelli, A., Traversa, M., Bonomo, K., Fiora, E., Conti, M., Anfossi, G., Costa, G., & Trovati, M. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1005 · Cited by 569 · cited 8×
“This kind of categorization was the same as that used in the 5-year follow-up (10).”
BackgroundMethodResultInfluentialSelf-citationFasting and Postchallenge Glycemia and Cardiovascular Disease Risk
Meigs, J. B., Nathan, D. M., D’Agostino, R. B., & Wilson, P. W. F. (2002) · Diabetes Care · doi:10.2337/diacare.25.10.1845 · Cited by 509
Cited by
Items 101–200 of 322
Impact on Diabetes Self-Management and Glycemic Control of a New Color-Based SMBG Meter
Schnell, O., Klausmann, G., Gutschek, B., García-Verdugo, R., & Hummel, M. (2017) · Journal of Diabetes Science and Technology · doi:10.1177/1932296817706376 · Cited by 30
“Furthermore, an epidemiological cohort study demonstrated a positive influence of frequent SMBG on diabetes-related morbidity and overall mortality.(13) Various national and international guidelines recommend regular SMBG for diabetes management and treatment support.”
BackgroundIntrinsic High Aerobic Capacity in Male Rats Protects Against Diet-Induced Insulin Resistance
Morris, E. M., Meers, G. M.-E., Ruegsegger, G. N., Wankhade, U. D., Robinson, T., Koch, L. G., Britton, S. L., Rector, R. S., Shankar, K., & Thyfault, J. P. (2019) · Endocrinology · doi:10.1210/en.2019-00118 · Cited by 26
Paing, A. C., McMillan, K. A., Kirk, A. F., Collier, A., Hewitt, A., & CHASTIN, S. F. M. (2019) · Journal of science and medicine in sport · doi:10.1016/j.jsams.2019.01.017 · Cited by 29
“Introduction In type 2 diabetes, postprandial glucose control is crucial to reduce the risk of cardiovascular complications and all-cause mortality.(1,2) However, even in people with type 2 diabetes with the recommended HbA1c (glycated haemoglobin) of less than 7% (53 mmol/mol), a high incidence of postprandial hyperg…”
BackgroundReimer, R. A., Grover, G. J., Koetzner, L., Gahler, R. J., Juneja, P., Lyon, M. R., & Wood, S. (2012) · Journal of Nutrition · doi:10.3945/jn.112.163204 · Cited by 27
Bonora, E., & CIGOLINI, M. (2016) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2016.03.002 · Cited by 26
Exercise and Postprandial Glycemic Control in Type 2 Diabetes
Kearney, M. L., & Thyfault, J. P. (2016) · Current Diabetes Reviews · doi:10.2174/1573399811666150615112441 · Cited by 29
Brod, M. I., Nikolajsen, A., Weatherall, J., & Pfeiffer, K. M. (2016) · Diabetes Therapy · doi:10.1007/s13300-016-0175-x · Cited by 25
“While research on diabetes management has focused primarily on the role of HbA1c and fasting plasma glucose (FPG) for the measurement of glycemic control, recent data suggest that blood glucose (BG) after eating or post-prandial blood glucose (PPG), also plays an important role in glycemic control and glycemic variabi…”
BackgroundPeng, J., Lu, J., Ma, X., Ying, L., Lu, W., Zhu, W., Bao, Y., & Zhou, J. (2018) · British Journal Of Nutrition · doi:10.1017/s0007114518003628 · Cited by 25
“Participant characteristics before and after intervention (Mean values and standard deviations) LI +MR (n 62) LI (n 61) Before After Change Before After Change Parameters Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD Age (years) 56·9 9·1 – – 56·5 8·4 – – Male–female (n) 30/32 – – 36/25 – – Body weight (kg) 67·2 10·4…”
BackgroundInfluentialReid, R. E. R., Thivel, D., & Mathieu, M.-E. (2019) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2018-0462 · Cited by 31
“A 14-year longitudinal study of individuals with type-2-diabetes showed that elevated blood glucose two-hours after meal consumption increases the risk for cardiovascular events by 50% and mortality by 89% (Cavalot et al. 2011).”
BackgroundBrod, M. I., Nikolajsen, A., Weatherall, J., & Pfeiffer, K. M. (2016) · Diabetes Therapy · doi:10.1007/s13300-016-0154-2 · Cited by 23
Sardina, P. D., Martin, J. S., Avery, J. C., & Braith, R. W. (2016) · Acta Diabetologica · doi:10.1007/s00592-016-0866-9 · Cited by 26
“OGTT is a powerful diagnostic tool for T2DM, and PPG120 values are predictive of cardiovascular events and all-cause mortality [18].”
Targeting One-Hour Postmeal Glucose: Is It Time for a Paradigm Switch in Diabetes Management?
Ceriello, A. (2017) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2017.0135 · Cited by 28
“10,11 Carotid intima-media thickness (CIMT) is a risk factor for CVD. 12 One-hour postchallenge glycemia has been found to be correlated with increased arterial stiffness 13 and CIMT in several studies.”
InfluentialCheng, P. C., Hsu, S. R., Cheng, Y. C., & Liu, Y. H. (2017) · PeerJ · doi:10.7717/peerj.3875 · Cited by 23
“Indeed, several studies have implicated hyperglycemia after meals in the development of cardiovascular disease (Cavalot et al., 2011; Node & Inoue, 2009; Ceriello, 2009).”
BackgroundImpact of energy turnover on the regulation of glucose homeostasis in healthy subjects
Büsing, F., Hägele, F. A., Nas, A., Hasler, M., Müller, M. J., & Bosy‐Westphal, A. (2019) · Nutrition and Diabetes · doi:10.1038/s41387-019-0089-6 · Cited by 24
Saisho, Y., Tanaka, K., Abe, T., Kawai, T., & Itoh, H. (2013) · Endocrine Journal · doi:10.1507/endocrj.ej13-0376 · Cited by 22
“Previous studies have suggested an association between postprandial glucose excursion and cardiovascular disease [11-15].”
BackgroundComparison between sitagliptin and nateglinide on postprandial lipid levels: The STANDARD study
Kojima, Y., Kaga, H., Hayashi, S., Kitazawa, T., Iimura, Y., 大野, 誠., Yoshitsugu, M., Fujiwara, M., & Hiyoshi, T. (2013) · World Journal of Diabetes · doi:10.4239/wjd.v4.i1.8 · Cited by 21
Faure, C., Charlot, K., Henri, S., Hardy‐Dessources, M., Hüe, O., & Antoine‐Jonville, S. (2016) · Clinical Science · doi:10.1042/cs20150461 · Cited by 23
Giorgino, F., Bonadonna, R., Gentile, S., Vettor, R., & Pozzilli, P. (2016) · Diabetes/Metabolism Research Reviews · doi:10.1002/dmrr.2775 · Cited by 17
“Furthermore, a 14-year follow-up study in patients with T2DM showed that PPG was an independent risk factor for CV events, while FPG was not [67].”
BackgroundHansen, R., Andersen, J., Vinther, A. S., Pielmeier, U., & Larsen, R. G. (2016) · International Journal of Sports Medicine · doi:10.1055/s-0042-113466 · Cited by 22
Moore, J. M., Salmons, H., Vinoskey, C., & Kressler, J. (2020) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2020.06.020 · Cited by 21
Smith, K., Davies, K. A. B., Stevenson, E., & West, D. J. (2020) · Frontiers in Nutrition · doi:10.3389/fnut.2020.587843 · Cited by 24
“the incidence of future cardiovascular events (10, 11).”
BackgroundLeg Fidgeting During Prolonged Sitting Improves Postprandial Glycemic Control in People with Obesity
Pettit‐Mee, R. J., Ready, S. T., Padilla, J., & Kanaley, J. A. (2021) · Obesity · doi:10.1002/oby.23173 · Cited by 21
Pal, R., Banerjee, M., & Bhadada, S. K. (2021) · Diabetic Medicine · doi:10.1111/dme.14515 · Cited by 21
Wang, Y., Wang, D., Cheng, Y., Jia, B., Yu, G., Yin, X., & Wang, Y. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000487287 · Cited by 22
Smith, K., Taylor, G., Brunsgaard, L. H., Walker, M., Davies, K. A. B., Stevenson, E., & West, D. J. (2022) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2022-002820 · Cited by 26
Lebovitz, H. E., Fleming, A., Cherrington, A. D., Joshi, S., Athalye, S. N., Loganathan, S., Vishweswaramurthy, A., Panda, J., & Marwah, A. (2022) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2022.2141569 · Cited by 21
Barale, C., Cavalot, F. L., Frascaroli, C., Bonomo, K., Morotti, A., Guerrasio, A., & Russo, I. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21144983 · Cited by 20
Self-citationChiavaroli, L., Pede, G. D., Dall’Asta, M., Cossu, M., Francinelli, V., Goldoni, M., Scazzina, F., & Brighenti, F. (2020) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2020.09.025 · Cited by 24
Hashemi‐Madani, N., Ismail‐Beigi, F., Khamseh, M. E., Malek, M., & Valojerdi, A. E. (2017) · European Journal of Preventive Cardiology · doi:10.1177/2047487317707293 · Cited by 19
Takao, T., Takahashi, K., Suka, M., Suzuki, N., & Yanagisawa, H. (2019) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2019.01.006 · Cited by 17
Takao, T., Suka, M., Yanagisawa, H., & Kasuga, M. (2020) · Journal of Diabetes Investigation · doi:10.1111/jdi.13403 · Cited by 19
Rydén, L., estable, G. D. T. D. L. S. E. D. C. S. D. Y. T. D. L. C. I., Grant, P. J., Anker, S. D., Berne, C., Cosentino, F., Danchin, N., Deaton, C., Escaned, J., Hammes, H. P., et al. (2014) · Revista Española de Cardiología · doi:10.1016/j.recesp.2013.10.015 · Cited by 37
A Plethora of GLP-1 Agonists: Decisions About What to Use and When
Samson, S. L., & Garber, A. J. (2016) · Current Diabetes Reports · doi:10.1007/s11892-016-0823-6 · Cited by 20
Zhang, X., Wongpipit, W., Sun, F., Sheridan, S. E., Huang, Y., Sit, C. H. P., & Wong, S. H. (2020) · Journal of Nutrition · doi:10.1093/jn/nxaa420 · Cited by 20
Riboldi, B. P., Luft, V. C., de Castilhos, C. D., de Cardoso, L. O., Schmidt, M. I., Barreto, S. M., de Sander, M. F., Matos, S. M. A., & Duncan, B. B. (2015) · Cardiovascular Diabetology · doi:10.1186/s12933-015-0181-8 · Cited by 17
“In a later study, the same authors [9] followed 505 of these individuals with diabetes for about 14 years and assessed the relationship of postprandial glycemia with mortality.”
BackgroundThe Inhibitory Effects of Yixing Black Tea Extracts on A-Glucosidase
Hao, W., Wang, M., & Lv, M. (2016) · Journal of Food Biochemistry · doi:10.1111/jfbc.12269 · Cited by 18
Numao, S., Kawano, H., Endo, N., Yamada, Y., Takahashi, M., Konishi, M., & Sakamoto, S. (2016) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2015-0702 · Cited by 17
Metformin inhibits mitochondrial complex I in intestinal epithelium to promote glycaemic control
Sebo, Z. L., Chakrabarty, R. P., Grant, R. A., D’Alessandro, K. B., Koss, A., Blum, J. L. E., Davidson, S. M., Reczek, C. R., & Chandel, N. S. (2026) · Nature Metabolism · doi:10.1038/s42255-026-01530-y · Cited by 23
Scholz, G. H., & Fleischmann, H. (2014) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018814556099 · Cited by 18
A Review of Cardiovascular Outcomes in the Treatment of People with Type 2 Diabetes
DAILEY, G. E., & Wang, E. (2014) · Diabetes Therapy · doi:10.1007/s13300-014-0091-x · Cited by 16
“follow-up to the San Luigi Gonzago Diabetes Study that investigated 505 people with T2DM found that both HbA1c and 2-h PPG levels were predictors of both CV events and all-cause mortality [46].”
BackgroundAuthorised EU health claim for arabinoxylan
Kellow, N. J., & Walker, K. Z. (2017) · Elsevier eBooks · doi:10.1016/b978-0-08-100922-2.00013-9 · Cited by 22
Insulin Resistance Correlates with the Arterial Stiffness before Glucose Intolerance
Fang, F., Liu, M., Cheng, X., Zhong, W., Miao, X., Li, J., Li, C., & Tian, H. (2014) · Internal Medicine · doi:10.2169/internalmedicine.53.0690 · Cited by 17
“The elevated plasma glucose level in diabetes or an impaired glucose tolerance is a risk factor for cardiovascular events and mortality (1-3).”
BackgroundPotential Drug Combinations to Reduce Cardiovascular Disease Burden in Diabetes
Pillarisetti, S. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2015.11.009 · Cited by 15
Johnson, E. L., Frías, J. P., & Trujillo, J. M. (2018) · Postgraduate Medicine · doi:10.1080/00325481.2018.1452515 · Cited by 16
“tor of cardiovascular disease and mortality [37,38], adding to the importance of recognizing when additional control of PPG is needed.”
BackgroundPaing, A. C., McMillan, K. A., Kirk, A. F., Collier, A., Hewitt, A., & CHASTIN, S. F. M. (2019) · European Journal of Applied Physiology · doi:10.1007/s00421-019-04261-z · Cited by 19
Kawaguchi, Y., Miyamoto, S., Hajika, Y., Ashida, N., Hirota, T., Masumoto, K., Sawa, J., Hamazaki, K., & Kumeda, Y. (2022) · Advances in Therapy · doi:10.1007/s12325-022-02138-w · Cited by 15
“In contrast, it has been suggested that postprandial hyperglycemia is associated with cardiovascular events and allcause mortality and is an independent risk factor for cardiovascular events [40, 41].”
BackgroundLundby‐Christensen, L., Vaag, A. A., Tarnow, L., Almdal, T., Lund, S. S., Wetterslev, J., Gluud, C. N., Boesgaard, T. W., Wiinberg, N., Perrild, H., et al. (2016) · BMJ Open · doi:10.1136/bmjopen-2015-008377 · Cited by 16
Balderas, C., Angulo, J., Sevilleja-Ortiz, A., Peiró, C., Vallejo, S., Dongil, P., de Ancos, B., & Sánchez‐Moreno, C. (2022) · Antioxidants · doi:10.3390/antiox11101953 · Cited by 17
“Reductions in plasma glucose concentrations may be particularly relevant given the relationship between cardiovascular events and all-cause mortality predicted by postprandial blood glucose [48].”
BackgroundKawaguchi, Y., Sawa, J., & Kumeda, Y. (2020) · Diabetes Therapy · doi:10.1007/s13300-020-00940-9 · Cited by 14
Late non-fasting plasma glucose predicts cardiovascular mortality independent of hemoglobin A1c
Wang, Y., & Fang, Y. (2022) · Scientific Reports · doi:10.1038/s41598-022-12034-6 · Cited by 13
Kim, K. J., & Kim, J. Y. (2024) · Food Science and Biotechnology · doi:10.1007/s10068-024-01607-y · Cited by 15
“Postprandial blood glucose levels predict diabetes complications, including cardiovascular disease, in the general population (Cavalot et al., 2011).”
Schnell, O., Alawi, H., Battelino, T., Ceriello, A., Diem, P., Felton, A., Grzeszczak, W., Harno, K., Kempler, P., Satman, I., et al. (2012) · Journal of Diabetes Science and Technology · doi:10.1177/193229681200600323 · Cited by 14
Davidson, M. H. (2014) · Postgraduate Medicine · doi:10.3810/pgm.2014.05.2756 · Cited by 13
Heiston, E. M., Ballantyne, A., Salvia, S. L., Musante, L., Erdbrügger, U., & Malin, S. K. (2022) · The Journal of Physiology · doi:10.1113/jp282274 · Cited by 14
“2005) and all-cause mortality (Cavalot et al .”
BackgroundKhalafi, M., Mojtahedi, S., Ostovar, A., Rosenkranz, S. K., & Korivi, M. (2022) · Obesity Reviews · doi:10.1111/obr.13459 · Cited by 16
“Both acute and chronic exercise training are associated with beneficial glycemic effects and metabolic health,64 whereas elevated glucose and insulin levels especially during postprandial states are major risk factors for CVDs.2 Aerobic exercise is widely recommended to improve glycemic control.”
BackgroundInfluentialLixisenatide reduces glycaemic variability in insulin‐treated patients with type 2 diabetes
Umpierrez, G. E., O'Neal, D. N., DIGENIO, A. G., Goldenberg, R., Hernández-Triana, E., Lin, J., Park, C., Renard, É., & Kovatchev, B. P. (2017) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12930 · Cited by 13
“Glucagon-like peptide-1 receptor agonists (GLP-1RAs) complement the effects of basal insulin by potentiating endogenous insulin responses to hyperglycaemic excursions, suppressing elevated glucagon secretion, promoting satiety, and (for some agents) slowing gastric emptying, therefore blunting postprandial hyperglycae…”
BackgroundInfluentialvon Schwartzenberg, R. J., & Turnbaugh, P. J. (2015) · Cell · doi:10.1016/j.cell.2015.11.012 · Cited by 12
“…levels, post-meal glucose levels are increasingly recognized as important risk factors for the development of cardiovascular disease and mortality (Cavalot et al., 2011), and the introduction of continuous glucose monitoring has improved glycemic control; for example in type 1 diabetics (Juvenile…”
BackgroundLow Carbohydrate Diets for Diabetic Cardiomyopathy: A Hypothesis
Kleissl-Muir, S., Rasmussen, B., Owen, A. J., Zinn, C., & Driscoll, A. L. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.865489 · Cited by 192
Jeong, K., Moon, S. J., Rachim, V. P., Song, Y., Cho, Y. M., & Park, S. (2025) · IEEE Journal of Biomedical and Health Informatics · doi:10.1109/jbhi.2025.3602827 · Cited by 13
“Dietary change can improve elevated post-prandial glycemic responses (PPGRs) [7], [8], posing a substantial risk for T2DM complications [9], [10].”
Rationale for treatment options for mealtime glucose control in patients with type 2 diabetes
Aronoff, S. L. (2017) · Postgraduate Medicine · doi:10.1080/00325481.2017.1285191 · Cited by 11
Pfeiffer, K. M., Sandberg, A., Nikolajsen, A., & Brod, M. I. (2017) · Journal of Medical Economics · doi:10.1080/13696998.2017.1377208 · Cited by 12
Imano, H., Iso, H., Kitamura, A., Yamagishi, K., Hayama‐Terada, M., Muraki, I., Okada, T., Umesawa, M., Ohira, T., Sankai, T., et al. (2018) · Circulation Journal · doi:10.1253/circj.cj-17-0950 · Cited by 12
Zhang, X., Yang, Z., Zhang, M., Zhu, Y., Zhao, Z., Huang, Z., Li, C., Zhou, M., Farmer, A. A., Tang, J.-L., et al. (2021) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2021.108672 · Cited by 12
Smedegaard, S. B., Mose, M., Hulmán, Á., Mikkelsen, U. R., Møller, N., Wegener, G., Jessen, N., & Rittig, N. F. (2021) · Nutrients · doi:10.3390/nu13020308 · Cited by 13
“Large glucose excursions and high glycemic variability have been associated with risk of cardiovascular disease [26] as well as impaired cognitive function [27].”
BackgroundPapakonstantinou, E., Galanopoulos, K., Kapetanakou, A. E., Gkerekou, M. A., & Skandamis, P. N. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph191811502 · Cited by 11
“High postprandial glycemia has been associated with chronic metabolic diseases such as type 2 diabetes [1,2], cardiovascular diseases [3], greater oxidative stress [4], and increased risk of mortality in people with [5] or without diabetes [6].”
BackgroundXiao, P.-J., Zeng, J., Lin, P., Tang, D., Yuan, E., Tu, Y.-G., Zhang, Q., Chen, J., Peng, D., & Yin, Z. (2022) · Molecules · doi:10.3390/molecules27217583 · Cited by 11
“Therefore, controlling postprandial blood glucose level is essential for the diabetes treatment and diabetes complications reduction [8].”
BackgroundBourne, J. E., Leary, S. D., Page, A. S., Searle, A., England, C. Y., Thompson, D., Andrews, R. C., Foster, C. E., & Cooper, A. R. (2023) · Pilot and Feasibility Studies · doi:10.1186/s40814-023-01283-5 · Cited by 16
Wang, Y. (2024) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd11020053 · Cited by 12
“Consistently, the current study suggests that non-fasting plasma glucose (PPG 4–7.9h ) may be used for cardiovascular risk assessment.”
BackgroundYano, Y., Hayakawa, M., Kuroki, K., Ueno, H., Yamagishi, S., Takeuchi, M., Eto, T., Nagata, N., Nakazato, M., Shimada, K., et al. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.12.006 · Cited by 11
Differential pharmacology and clinical utility of empagliflozin in type 2 diabetes
Davis, S. N., & Munir, K. M. (2016) · Clinical Pharmacology Advances and Applications · doi:10.2147/cpaa.s77754 · Cited by 16
“…mg ⋅ h/dL and − 91.6 mg ⋅ h/dL for empagliflozin 10 mg and 25 mg, respectively), and reduced postmeal glucose ( P , 0.001) was maintained at day 28 ( − 85.5 mg ⋅ h/dL and − 104.9 mg ⋅ h/ dL for empagliflozin 10 mg and 25 mg, respectively), along with reduced 24-hour adjusted mean glucose ( −…”
InfluentialMajithia, A. R., Wiltschko, A. B., Zheng, H., Walford, G. A., & Nathan, D. M. (2017) · Journal of Diabetes Science and Technology · doi:10.1177/1932296817725756 · Cited by 11
Corrales, P. J. P., Bellido, V., & Ampudia‐Blasco, F. J. (2018) · Revista Clínica Española (English Edition) · doi:10.1016/j.rceng.2018.12.002 · Cited by 18
Sacchetti, M., Haxhi, J., Sgrò, P., di Palumbo, A. S., Nicolò, A., Bellini, A., Bazzucchi, I., & Luigi, L. D. (2021) · European Journal of Nutrition · doi:10.1007/s00394-021-02512-4 · Cited by 11
Lixisenatide – A New Glucagon-like Peptide 1 Receptor Agonist in the Treatment of Type 2 Diabetes
Vidal, J. (2010) · touchREVIEWS in Endocrinology · doi:10.17925/ee.2013.09.02.76 · Cited by 15
AGP and Nutrition – Analysing postprandial glucose courses with CGM
Kröger, J., Siegmund, T., Schubert-Olesen, O., Keuthage, W., Lettmann, M., Richert, K., & Pfeiffer, A. F. H. (2021) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2021.108738 · Cited by 12
Binou, P., Stergiou, A., Kosta, O. A., Tentolouris, N., & Karathanos, V. Τ. (2022) · European Journal of Nutrition · doi:10.1007/s00394-022-02913-z · Cited by 11
Postprandial Glucose: A Variable in Continuum
Joshi, S., Kesavadev, J., M., P. K. K., Saboo, B., Mehta, A., Bhattacharyya, A., Sosale, A., Jabbar, P. K., Santosh, R., Deshmukh, V. C., et al. (2025) · Clinical Medicine Insights Endocrinology and Diabetes · doi:10.1177/11795514251370507 · Cited by 12
“The San Luigi Gonzaga Diabetes study 33 concluded that blood glucose levels 2h after meals was an independent risk factor of cardiovascular disease.”
Yan, R., Hu, Y., Li, F.-F., Jiang, L., Xu, X., Wang, J., Zhang, Y., Ye, L., Lee, K., Su, X., et al. (2019) · International Journal of Endocrinology · doi:10.1155/2019/1267475 · Cited by 10
“Postprandial glucose was a strong predictor of cardiovascular events and all-cause mortality in a long-term follow-up [18].”
BackgroundLammi, C., Bartolomei, M., Bollati, C., Cecchi, L., Bellumori, M., Sabato, E., Vistoli, G., Mulinacci, N., & Arnoldi, A. (2021) · Antioxidants · doi:10.3390/antiox10071133 · Cited by 10
“Post-prandial glucose has been associated with a higher incidence of cardiovascular events in patients with [9] and without [10] diabetes.”
BackgroundAnderson, B. J., Curtis, A. M., Jen, A., Thomson, J. A., Clegg, D., Jiang, P., Coon, J. J., Overmyer, K. A., & Toh, H. (2023) · Lab Animal · doi:10.1038/s41684-023-01268-0 · Cited by 10
Corrales, P. J. P., Bellido, V., & Ampudia‐Blasco, F. J. (2018) · Revista Clínica Española · doi:10.1016/j.rce.2018.06.015 · Cited by 18
Liu, R., Zhao, J., Guo, J., Liu, X., Yu, J., Wang, H., Li, Y., Sun, C., & Liu, L. (2019) · Food & Function · doi:10.1039/c8fo02321b · Cited by 10
Extracellular Vesicles in Metabolic and Vascular Insulin Resistance
Malin, S. K., & Erdbrügger, U. (2024) · Journal of Vascular Research · doi:10.1159/000538197 · Cited by 12
Santos‐Báez, L. S., Díaz‐Rizzolo, D. A., Borhan, R., Popp, C. J., Sordi‐Guth, A., DeBonis, D., Manoogian, E. N. C., Panda, S., Cheng, B., & Laferrère, B. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16160 · Cited by 9
Lemke, M. K., Oberlin, D. J., Apostolopoulos, Y., Hege, A., Sönmez, S., & Wideman, L. (2021) · Work · doi:10.3233/wor-213472 · Cited by 8
Postprandial Plasma Glucose between 4 and 7.9 h May Be a Potential Diagnostic Marker for Diabetes
Wang, Y., Fang, Y., Aberson, C. L., Charchar, F. J., & Ceriello, A. (2024) · Biomedicines · doi:10.3390/biomedicines12061313 · Cited by 8
“Its positive correlation with cardiovascular disease incidence [12–15] and mortality [16], cancer mortality [17,18], and all-cause mortality [12–14, 17,19] Recent findings highlight the stability and significance of postprandial glucose levels measured between 4 and 7.9 h after a meal (PPG 4–7.9h )…”
BackgroundInfluentialHansen, D., Verboven, K., van Dijk, J., Zorenc, A. H. G., Minten, L., Smeets, K., Verdijk, L. B., & van Loon, L. J. C. (2018) · European Journal of Sport Science · doi:10.1080/17461391.2018.1483428 · Cited by 9
Yang, K., Yang, Y., Xie, Y., Mao, Y., Li, X., & Guo, Q. Q. (2023) · Food Hydrocolloids · doi:10.1016/j.foodhyd.2023.108685 · Cited by 9
BRIGHT Guidelines on Self-Monitoring of Blood Glucose
Basit, A., Khan, A., & Khan, R. A. (2014) · Pakistan Journal of Medical Sciences · doi:10.12669/pjms.305.6006 · Cited by 10
Nygaard, H., Grindaker, E., Rønnestad, B. R., Holmboe‐Ottesen, G., & Høstmark, A. T. (2017) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2016-0467 · Cited by 15
“Postprandial glycemia do show a stronger correlation to disease and mortality than fasting blood glucose (Cavalot et al. 2011; Cavalot et al. 2006; DECODE 1999; DECODE 2001; Sasso et al. 2004; Temelkova-Kurktschiev et al. 2000).”
BackgroundKomi, R., Tanaka, F., Omama, S., Ishibashi, Y., Tanno, K., Onoda, T., Ohsawa, M., Tanaka, K., Okayama, A., Nakamura, M., et al. (2018) · Hypertension Research · doi:10.1038/s41440-018-0042-4 · Cited by 10
“Previous epidemiological studies have demonstrated the combined effect of prehypertension or hypertension and diabetes on the incidence of CVD [13, 35, 36].”
BackgroundInfluentialKondo-Ando, M., Seino, Y., Morikawa, R., Kana, N., Todoroki, H., Kawakami, T., Asada, Y., Yoshimoto, R., Tanaka, C., Okamoto, K., et al. (2019) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2019.107415 · Cited by 11
Khalafi, M., Symonds, M. E., Ghasemi, F., Rosenkranz, S. K., Rohani, H., & Sakhaei, M. H. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110741 · Cited by 10
Focusing on Cardiovascular Disease in Type 2 Diabetes Mellitus: An Introduction to Bromocriptine QR
Bell, D. S. H. (2012) · Postgraduate Medicine · doi:10.3810/pgm.2012.09.2598 · Cited by 8
“A subsequent 14-year follow-up of this study concluded that both HbA 1c and PPG (but not FPG) levels predicted cardiovascular-related events and all-cause mortality.(45) In the Diabetes Epidemiology: Collaborative”
BackgroundChawla, R., Mukherjee, J. J., Chawla, M. S., Kanungo, A. K., Shunmugavelu, M., & Das, A. K. (2021) · Medical Sciences · doi:10.3390/medsci9020038 · Cited by 10
Hollekim-Strand, S. M., Malmo, V., Follestad, T., Wisløff, U., & Ingul, C. B. (2015) · Nutrition Journal · doi:10.1186/s12937-015-0069-1 · Cited by 10
“Most of the day is spent in the postprandial state and frequent ingestion of energy dense food, rich in processed carbohydrates, saturated fats and salt (fast-food), increases the risk of cardiometabolic diseases [1–3].”
BackgroundSun, D., van Greevenbroek, M. M. J., Scheijen, J. L. J. M., Kelly, J. F., Schalkwijk, C. G., & Wouters, K. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae640 · Cited by 7
Ihana‐Sugiyama, N., Tsujimoto, T., Yamamoto‐Honda, R., Kishimoto, M., Kajio, H., Noto, H., Kakei, M., & Noda, M. (2014) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-6-48 · Cited by 8
A novel option for prandial insulin therapy: inhaled insulin
Dailey, G., Ahmad, A., Polsky, S., & Shah, V. N. (2016) · Postgraduate medicine · doi:10.1080/00325481.2016.1229555 · Cited by 6
“postprandial plasma glucose (PPG) and cardiovascular events has been controversial [4,5], evidence is emerging that sug-”
BackgroundPaing, A. C., Kirk, A. F., Collier, A., Kubiak, T., & CHASTIN, S. F. M. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.10.010 · Cited by 8
Metadata
- Authors
- Cavalot, F., Pagliarino, A., Valle, M., Di Martino, L., Bonomo, K., Massucco, P., Anfossi, G., & Trovati, M.
- Affiliations
- Ospedale San Luigi Gonzaga (IT)
- Medicine and Metabolic Disease Unit, Department of Clinical and Biological Sciences, San Luigi Gonzaga Faculty of Medicine of Turin University, San Luigi Gonzaga Hospital, Turin, Italy
- Corresponding author
- Trovati, Mariella
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2011-09-15
- Volume
- 34
- Issue
- 10
- Pages
- 2237-2243
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC3177732
- OpenAlex
- W2079118015
- Cited by
- 322
- References
- 25
- Citations by year
- 2026: 12 · 2025: 13 · 2024: 15 · 2023: 16 · 2022: 24 · 2021: 21 · 2020: 25 · 2019: 24 · 2018: 24 · 2017: 27 · 2016: 32 · 2015: 22 · 2014: 27 · 2013: 20 · 2012: 17
- FWCI
- 17.32
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Institutional Research Information System University of Turin (University of Turin) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- type 2 diabetes, postprandial blood glucose, cardiovascular events, all-cause mortality, HbA1c, glycemic control, cardiovascular risk factors, long-term prognosis
- MeSH terms
- Aged, Blood Glucose, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Female, Follow-Up Studies, Glycated Hemoglobin, Humans, Male, Middle Aged, Proportional Hazards Models, Postprandial Period
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.